COVID-19 Pandemic: The Existing Challenges and Available Solution; Evidence from a Systematic Review

Mohammad Injamul Hoq, Hamidur Rahman Sime, M. Hossain, A. Awal, M. Hoque
{"title":"COVID-19 Pandemic: The Existing Challenges and Available Solution; Evidence from a Systematic Review","authors":"Mohammad Injamul Hoq, Hamidur Rahman Sime, M. Hossain, A. Awal, M. Hoque","doi":"10.15294/UJPH.V10I1.39513","DOIUrl":null,"url":null,"abstract":"Coronavirus disease (COVID-19) is presently the most important topic worldwide. However, no vaccine or specific anti-viral treatment for the disease has been shown to be effective. In this emergency, identifying risk factors, preventive measures and estimating challenges which control available drug options for COVID-19 are key to mitigating the severity of the pandemic until specific drugs or vaccines become available. Therefore, this study aims to identify possible factors which affect these drug options. This study searched PubMed database using necessary Boolean operators from December 31st to March 31st 2020 in order to identify common risk factors, preventive measures, information regarding control challenges & evidence on the available drug options against COVID-19. Risk factors were found to be human-animal interactions, males, aged peopleand people with co-morbidity. Furthermore, protective factors comprised of personal hygiene etiquette maintenance, rapid identification, isolation and informing (3I tools) of the COVID-19 cases and media coverage on COVID-19. Till date, anti-viral drugs like remdesivir, chloroquine, lopinavir/ritonavir and traditional Chinese medicine (TCM) are available options to fight against COVID-19. More research is needed to determine other how to control the disease until specific treatment options are available as well as risk factors, and preventive measures.","PeriodicalId":30840,"journal":{"name":"Unnes Journal of Public Health","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Unnes Journal of Public Health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15294/UJPH.V10I1.39513","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Coronavirus disease (COVID-19) is presently the most important topic worldwide. However, no vaccine or specific anti-viral treatment for the disease has been shown to be effective. In this emergency, identifying risk factors, preventive measures and estimating challenges which control available drug options for COVID-19 are key to mitigating the severity of the pandemic until specific drugs or vaccines become available. Therefore, this study aims to identify possible factors which affect these drug options. This study searched PubMed database using necessary Boolean operators from December 31st to March 31st 2020 in order to identify common risk factors, preventive measures, information regarding control challenges & evidence on the available drug options against COVID-19. Risk factors were found to be human-animal interactions, males, aged peopleand people with co-morbidity. Furthermore, protective factors comprised of personal hygiene etiquette maintenance, rapid identification, isolation and informing (3I tools) of the COVID-19 cases and media coverage on COVID-19. Till date, anti-viral drugs like remdesivir, chloroquine, lopinavir/ritonavir and traditional Chinese medicine (TCM) are available options to fight against COVID-19. More research is needed to determine other how to control the disease until specific treatment options are available as well as risk factors, and preventive measures.
新冠肺炎大流行:现有挑战和可用解决方案;系统审查的证据
冠状病毒病(COVID-19)是当前全球最重要的话题。然而,没有疫苗或特定的抗病毒治疗被证明是有效的。在这种紧急情况下,确定风险因素、采取预防措施并估计控制COVID-19现有药物选择的挑战,是在获得特定药物或疫苗之前减轻大流行严重程度的关键。因此,本研究旨在确定影响这些药物选择的可能因素。本研究在2020年12月31日至3月31日期间使用必要的布尔运算符检索PubMed数据库,以确定共同的风险因素、预防措施、有关控制挑战的信息以及有关COVID-19可用药物选择的证据。危险因素包括人与动物的相互作用、男性、老年人和合并症患者。此外,保护因素包括个人卫生礼仪维护、快速识别、隔离和通报(3I工具)COVID-19病例以及媒体对COVID-19的报道。迄今为止,瑞德西韦、氯喹、洛匹那韦/利托那韦等抗病毒药物和中药都是对抗COVID-19的可用选择。需要更多的研究来确定控制疾病的其他方法,直到有具体的治疗方案以及风险因素和预防措施。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.80
自引率
0.00%
发文量
0
审稿时长
24 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书